Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic
Brufsky, A., J. Medical Virology, doi:10.1002/jmv.25887 (Theory)
Brufsky, Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic, , A., J. Medical Virology, doi:10.1002/jmv.25887 (Theory)
Apr 2020   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Theory on the effectiveness of HCQ. HCQ has been shown to block the polarization of macrophages to an M1 inflammatory subtype and is predicted to interfere with glycosylation of a number of proteins involved in the humoral immune response, possibly including the macrophage FcR gamma IgG receptor and other immunomodulatory proteins, potentially through inhibition of UDP-N-acetylglucosamine 2-epimerase. In combination with potential other immunomodulatory effects, this could possibly blunt the progression of COVID-19 pneumonia all to way up to ARDS.
Brufsky et al., 15 Apr 2020, peer-reviewed, 1 author.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: Received: 10 April 2020 | Accepted: 13 April 2020 DOI: 10.1002/jmv.25887 REVIEW Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic Adam Brufsky MD, PhD UPMC Hillman Cancer Center, Magee Women's Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania Abstract Coronavirus disease‐2019 (COVID‐19) infection and its severity can be explained by Correspondence Adam Brufsky, MD, PhD, UPMC Hillman Cancer Center, Magee Women's Hospital, University of Pittsburgh School of Medicine, Suite 4628, 300 Halket Street, Pittsburgh, PA 15213. Email: brufskyam@upmc.edu the concentration of glycosylated severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) viral particles in the lung epithelium, the concentration of glycosylated angiotensin‐converting enzyme receptor 2 (ACE2) in the lung epithelium, and the degree and control of the pulmonary immune response to the SARS‐CoV‐2 spike protein at approximately day 8 to 10 after symptom onset, which may be related to both. Binding of ACE2 by SARS‐CoV‐2 in COVID‐19 also suggests that prolonged uncontrolled hyperglycemia, and not just a history of diabetes mellitus, may be important in the pathogenesis of the disease. It is tempting to consider that the same mechanism acts in COVID‐19 as in SARS, where an overactive macrophage M1 inflammatory response, as neutralizing antibodies to the SARS‐CoV‐2 spike protein form at day 7 to 10, results in acute respiratory distress syndrome (ARDS) in susceptible patients. It also allows consideration of agents, such as hydroxychloroquine, which may interfere with this overly brisk macrophage inflammatory response and perhaps influence the course of the disease, in particular, those that blunt but do not completely abrogate the M1 to M2 balance in macrophage polarization, as well as viral load, which in SARS appears to be temporally related to the onset of ARDS. KEYWORDS antibody‐mediated cell‐mediated cytotoxicity, antiviral agents, SARS coronavirus 1 | ROLE OF THE ACE 2 R ECEPTOR I N COV I D‐ 19 INFECTION to help us with this understanding. Rapid publication of peer‐ reviewed data has defined the possible risk factors for COVID‐19, its clinical course, and its possible epidemiology. In this unusual time of a We are all struggling to understand the human catastrophe of the public health emergency, numerous non‐peer‐reviewed manuscripts coronavirus disease‐2019 (COVID‐19) epidemic. As of April 12, have been uploaded to preprint servers, and their unreviewed data 2020, there were 557043 cases of documented COVID‐19 infection and conclusions must be evaluated in this spirit. in the United States, and 21952 deaths.1 Our economy except for Nevertheless, data both published and in preprint form point to a limited sectors has come to a complete halt as we practice physical tantalizing hypothesis: that COVID‐19 infection and its severity can be distancing to try to mitigate the effects of the pandemic. explained by the concentration of glycosylated severe acute respiratory In the 10 weeks since COVID‐19 began to accelerate, there has syndrome‐coronavirus 2 (SARS‐CoV‐2) viral particles in the lung epithe- been a flurry of information from corners expected and unexpected lium, the concentration of glycosylated angiotensin‐converting enzyme ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- - This..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit